BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27287825)

  • 21. Assessment of the Target Engagement and D-Serine Biomarker Profiles of the D-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756.
    Howley E; Bestwick M; Fradley R; Harrison H; Leveridge M; Okada K; Fieldhouse C; Farnaby W; Canning H; Sykes AP; Merchant K; Hazel K; Kerr C; Kinsella N; Walsh L; Livermore DG; Hoffman I; Ellery J; Mitchell P; Patel T; Carlton M; Barnes M; Miller DJ
    Neurochem Res; 2017 Nov; 42(11):3279-3288. PubMed ID: 28780732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties.
    Huang CC; Wei IH; Yang HT; Lane HY
    Neurochem Res; 2023 Jul; 48(7):2066-2076. PubMed ID: 36786942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
    Adage T; Trillat AC; Quattropani A; Perrin D; Cavarec L; Shaw J; Guerassimenko O; Giachetti C; Gréco B; Chumakov I; Halazy S; Roach A; Zaratin P
    Eur Neuropsychopharmacol; 2008 Mar; 18(3):200-14. PubMed ID: 17681761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal D-amino acid oxidase contributes to mechanical pain hypersensitivity induced by sleep deprivation in the rat.
    Wei H; Gong N; Huang JL; Fan H; Ma AN; Li XY; Wang YX; Pertovaara A
    Pharmacol Biochem Behav; 2013 Oct; 111():30-6. PubMed ID: 23958579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of Brain d-Serine Mediates Recovery of Cognitive Function after Traumatic Brain Injury.
    Liraz-Zaltsman S; Slusher B; Atrakchi-Baranes D; Rosenblatt K; Friedman Levi Y; Kesner E; Silva AJ; Biegon A; Shohami E
    J Neurotrauma; 2018 Jul; 35(14):1667-1680. PubMed ID: 29648983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial.
    Lin CY; Liang SY; Chang YC; Ting SY; Kao CL; Wu YH; Tsai GE; Lane HY
    World J Biol Psychiatry; 2017 Aug; 18(5):357-368. PubMed ID: 26691576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
    Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
    FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats.
    Gong N; Gao ZY; Wang YC; Li XY; Huang JL; Hashimoto K; Wang YX
    J Pharmacol Exp Ther; 2011 Jan; 336(1):282-93. PubMed ID: 20952482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1).
    Kapoor R; Lim KS; Cheng A; Garrick T; Kapoor V
    Brain Res; 2006 Aug; 1106(1):205-210. PubMed ID: 16828464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine.
    Alt J; Rojas C; Wozniak K; Wu Y; Ferraris D; Tsukamoto T; Slusher B
    Anal Biochem; 2011 Dec; 419(2):106-9. PubMed ID: 21889486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
    Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE
    JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual role of D-amino acid oxidase in experimental pain models.
    Sharma J; Kulshrestha R; Singh N; Jaggi AS
    Eur J Pharmacol; 2019 Jul; 855():98-102. PubMed ID: 31059710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. d-Serine and d-Alanine Regulate Adaptive Foraging Behavior in
    Saitoh Y; Katane M; Miyamoto T; Sekine M; Sakai-Kato K; Homma H
    J Neurosci; 2020 Sep; 40(39):7531-7544. PubMed ID: 32855271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
    Fradley R; Goetghebeur P; Miller D; Burley R; Almond S; Gruart I Massó A; Delgado García JM; Zhu B; Howley E; Neill JC; Grayson B; Gaskin P; Carlton M; Gray I; Serrats J; Davies CH
    Neurochem Res; 2023 Oct; 48(10):3027-3041. PubMed ID: 37289348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.
    Hin N; Duvall B; Berry JF; Ferraris DV; Rais R; Alt J; Rojas C; Slusher BS; Tsukamoto T
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2088-91. PubMed ID: 26965861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain.
    Hopkins SC; Zhao FY; Bowen CA; Fang X; Wei H; Heffernan ML; Spear KL; Spanswick DC; Varney MA; Large TH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):502-11. PubMed ID: 23520265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia.
    Errico F; Mothet JP; Usiello A
    J Pharm Biomed Anal; 2015 Dec; 116():7-17. PubMed ID: 25868730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited proteolysis and X-ray crystallography reveal the origin of substrate specificity and of the rate-limiting product release during oxidation of D-amino acids catalyzed by mammalian D-amino acid oxidase.
    Vanoni MA; Cosma A; Mazzeo D; Mattevi A; Todone F; Curti B
    Biochemistry; 1997 May; 36(19):5624-32. PubMed ID: 9153402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contributions of spinal D-amino acid oxidase to chronic morphine-induced hyperalgesia.
    Ma S; Li XY; Gong N; Wang YX
    J Pharm Biomed Anal; 2015 Dec; 116():131-8. PubMed ID: 25850373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel spinal dorsal horn astroglial D-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance.
    Gong N; Li XY; Xiao Q; Wang YX
    Anesthesiology; 2014 Apr; 120(4):962-75. PubMed ID: 23928652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.